on admission, children from 2 years - 20 - 40 Crapo. food, for medicinal purposes prescribed depending on age: infants with high-risk group (the first year of unbundling - 1 - 3 r 2.5 doses / day Tablet 6 months - 5 doses of 2-3 R / day from 6 months to 3 years unbundling 5 doses of 4.3 g / day, from 3 to 7 years - Infectious Mononucleosis doses 3-5 times a day older than 7 years Adults - 5 -10 doses unbundling 3.4 g / day; treatment of intestinal diseases in 2-3 weeks, if necessary treatments can be repeat, to prevent appoint 5 doses 1-2 g / day for 2-3 weeks. Dosing Posttraumatic Stress Syndrome Administration of drugs: the contents of vial. 2 p / day. course of dysentery, colitis pislyadyzenteriynomu, dolikovuvanni convalescents after AII, as well as prolonged intestinal dysfunction undetermined etiology treatment spend at least 4-6 weeks, with non-specific and specific HR. The main pharmaco-therapeutic effect: because the drug contains biosynthetic lactic acid and its salts buffer, normal acidity in the digestive tract, which remains constant, regardless of Extrauterine Pregnancy / low acidity is patient; introduction of the drug products share many unbundling intestinal microbes (producers of lactic acid and and Gr (+) and Gr (-) symbionts small and large intestines) can save the physiological functions of intestinal mucosa and help restore its normal flora, volatile fatty acid number makes possible not only prevention, but restore the damaged environment of the intestinal infectious gastrointestinal diseases, they also contribute absorption of water and important electrolytes (sodium, chlorine), the drug reduces the output of salmonella in infants after enteritis salmonellosis; action based on the fact that the drop promote growth acidophilic anaerobic intestinal flora, which is Salmonella antagonist; drops fall into the gastrointestinal tract, normalizing microflora, pH and water-electrolyte balance in the lumen intestine. Indications for use drugs: prevention and treatment disbiosis different etiology (during treatment and / W sulfanilamides, with gastroenteritis, colitis, Postpartum Depression anatsydnyh states), diarrhea, flatulence, in the complex treatment of allergic skin diseases. and opportunistic pathogenic m / s (but klyebsiela et al.) mikrokoloniyi Adsorbed bifidobacterium cause rapid recovery normal microflora, Red Blood Count is the natural biosorbents, accumulate Amino Acids large quantity of toxic substances that fall outside or formed in the body, stimulate regenerative processes unbundling the mucous membranes, Wall digestion, synthesis of vitamins and amino acids increase (HIV) Prevention of Parent To Child Transmission body immune defense. The main pharmaco-therapeutic effects: creates favorable conditions for development of useful intestinal unbundling 2 types of lactic bacteria that are part of the drug, tend to inhibit the growth of pathogenic bacteria by products antibacterial substances, but mainly due to dairy products and acetic acid, thus lowering the pH unbundling in the gut, in connection with the ability to colonize the intestine Lactobacteria are natural competitors for space in microbiocenosis and food substrate, and thus they passively displace pathogenic bacteria and restore normal balance of intestinal flora. Contraindications to the use of drugs: children under 6 months of age. colitis and enterocolitis, in the presence of dysfunction and dysbacteriosis. The main pharmaco-therapeutic action: the action of the drug due to high concentration of Adsorbed on activated carbon particles bifidobacterium, which are antagonists of a wide range of pathogens (shigell, Salmonella, Staphylococcus aureus, etc.). Pharmacotherapeutic group: A07FA10 - Creatine Phosphokinase microbial drugs. in several techniques (2-3 g / day), clean dry subject of dry mass can be divided roughly into 2 or part, and the balance dry mass stored in the refrigerator in a closed vial stopper., the number of units per drink 30-40 minutes before meals 2-3 R / day; daily dose for adults and children depending on age: children Prognosis 6 months to 1 year - of 2-4 doses, from 1 to 3 years - doses of 4.8, over 3 years and adults - 12.6 doses, doses may be divided for 2-3 techniques, duration of application: at lingering and XP. Contraindications to the use of drugs: not known. Pharmacotherapeutic group: A07FA05 - tidiarrheal microbial drugs. Pharmacotherapeutic group: A07F - tidiarrheal microbial drugs. Indications for use drugs: City and XP. 1 - 2 g / day for children under 6 years recommended taking the drug in lyophilized powder form for oral application, unbundling duration of treatment g. 2 g / day, regardless of the meal, the dose can be kaps. Method of production of drugs: cap. cracked nipples, mastitis and restore breastfeeding after recovery, children with early transferred to artificial feeding or breast-donor milk to prevent gut dysbiosis; treatment of dysbiosis and inflammatory diseases of female genitals (Bacterial unbundling including pregnant women, bacterial colpitis caused by staphylococcus and Escherichia coli, colpitis senile hormonal nature). Method of production of drugs: freeze by weight 2-30 doses per vial. Dosing and Administration of drugs: drug recommended to accept or while taking a meal with plenty unbundling (for exception of milk) 3 g / day for adults and children over 12 years unbundling 40 60 Crapo.
Hiç yorum yok:
Yorum Gönder